Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

HOME
Search

Original Article

난치중증근무력증 환자의 치료에 대한 권고합의안: 이형수, 정혜윤, 김승우, 손은희, 남태승, 신경진, 강사윤, 김현진, 박진성, 윤별아, 석흥열, 봉정빈, 정연경, 홍윤호, 신하영; J Mult Scler Neuroimmunol. 2024;15(2):59-71. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.59-71
Cited By 3; Full text PubReader ePub PDF

Review Article

클라드리빈에대한종설(개발부터임상그리고실제치료에이르기까지): 신경진; J Mult Scler Neuroimmunol. 2024;15(2):55-58. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.55-58; Full text PubReader ePub PDF

Review Article

다발성경화증 환자들에서 Ocrelizumab의 임상적 유용성에 대한 고찰: 안석원; J Mult Scler Neuroimmunol. 2024;15(2):49-54. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.49-54; Full text PubReader ePub PDF

Review Article

시신경척수염범주질환에서 Eculizumab의 치료적 역할: 김지은, 안석원; J Mult Scler Neuroimmunol. 2024;15(2):43-48. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.43-48; Full text PubReader ePub PDF

Neuroimage

대뇌 실질을 침범한 IgG4연관비후경수막염: 김기훈, 김수현, 현재원, 김호진; J Mult Scler Neuroimmunol. 2024;15(1):40-41. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.40; Full text PubReader ePub PDF

Case Report

시신경척수염 범주질환 환자의 감정실금 증례 1: 안석원; J Mult Scler Neuroimmunol. 2024;15(1):35-39. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.35; Full text PubReader ePub PDF

Case Report

다발경화증 환자에서 리툭시맙 치료 중 발생한 호중구 감소증: 김기훈, 김수현, 현재원, 김호진; J Mult Scler Neuroimmunol. 2024;15(1):31-34. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.31; Full text PubReader ePub PDF

Review Article

자가면역 노드병증: 언제 의심하고, 어떻게 치료할까?: 민영기, 신하영, 성정준; J Mult Scler Neuroimmunol. 2024;15(1):23-30. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.23; Full text PubReader ePub PDF

Review Article

시신경척수염 범주질환의 재발 방지 항체 치료: 현재원; J Mult Scler Neuroimmunol. 2024;15(1):17-22. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.17; Full text PubReader ePub PDF

Review Article

중추신경계 염증성 질환의 감별 진단을 위한 영상 바이오마커: 권순욱; J Mult Scler Neuroimmunol. 2024;15(1):7-16. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.7; Full text PubReader ePub PDF

Review Article

다발경화증의 진행과 예후 예측인자: 임상적-영상적 측면: 양지원; J Mult Scler Neuroimmunol. 2024;15(1):1-6. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.1; Full text PubReader ePub PDF Supplementary Material

Neuroimage

다발경화증과 유사하게 발현한 동종 조혈모세포이식 후 중추신경계 이식편대숙주반응: 이석윤, 신경진, 오성일; J Mult Scler Neuroimmunol. 2023;14(2):137-138. Published online December 31, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.2.137; Full text PubReader ePub PDF

Brief Communication

Teriflunomide 치료와 관련된 탈모: 허운창, 강사윤; J Mult Scler Neuroimmunol. 2023;14(2):134-136. Published online December 31, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.2.134; Full text PubReader ePub PDF

Case Report

압통을 동반한 측두부 두통으로 발현한 혈관염 증례: 박찬영, 정해봉, 안석원; J Mult Scler Neuroimmunol. 2023;14(2):130-133. Published online December 31, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.2.130; Full text PubReader ePub PDF

Case Report

종괴형성 병변을 보인 다발경화증 증례: 강유진, 이상곤, 안석원; J Mult Scler Neuroimmunol. 2023;14(2):125-129. Published online December 31, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.2.125; Full text PubReader ePub PDF

Volume 17, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

6,065	Autoimmune Nodopathy: When to Suspect and How to Treat?
5,221	National Consensus Guidance for Management of Refractory Myasthenia Gravis
3,911	The Clinical Utility of the Ocrelizumab for the Patients with Multiple Sclerorsis
2,942	Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
2,851	Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis

Cited By 3	National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis
Cited By 1	Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders
Cited By 1	Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2026 by Korean Society of Neuroimmunology.